2002
DOI: 10.1152/ajpgi.00308.2001
|View full text |Cite
|
Sign up to set email alerts
|

A phosphorylated phloretin derivative. Synthesis and effect on intestinal Na+-dependent phosphate absorption

Abstract: Peerce, Brian E., and Rebecca Clarke. A phosphorylated phloretin derivative. Synthesis and effect on intestinal Na ϩ -dependent phosphate absorption.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2005
2005
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(5 citation statements)
references
References 34 publications
0
5
0
Order By: Relevance
“…In severe renal failure and end‐stage renal disease, one possible therapeutic target to control hyperphosphatemia is the development of compounds that inhibit intestinal sodium‐dependent Pi cotransporters (12–15). Inhibiting intestinal Pi absorption by inhibition of type IIb transporter by FGF23 would be a desirable method to control serum Pi levels in patients with chronic renal disease (CRF) or undergoing dialysis.…”
Section: Discussionmentioning
confidence: 99%
“…In severe renal failure and end‐stage renal disease, one possible therapeutic target to control hyperphosphatemia is the development of compounds that inhibit intestinal sodium‐dependent Pi cotransporters (12–15). Inhibiting intestinal Pi absorption by inhibition of type IIb transporter by FGF23 would be a desirable method to control serum Pi levels in patients with chronic renal disease (CRF) or undergoing dialysis.…”
Section: Discussionmentioning
confidence: 99%
“…Phosphonoformate (PFA, a phosphonocarboxylate) has a K i value of 0.37 mM in rat small intestine BBMVs, which indicates a low affinity of NPT2b for PFA as compared to P i [ 115 ]. 2′-Phosphophloretin (2′-PP), a derivative of the plant chalcone phloretin, more strongly inhibits Na + -dependent P i uptake, with K i values of 38 ± 7 nM in rabbit intestinal BBMVs and 42 ± 8 nM in rat intestinal BBMVs [ 116 ]. Pentavalent arsenate can be transported by NPT2b and also acts as a competitive inhibitor of NPT2b (K i = 51 µM for rat Npt2b in Xenopus oocytes) [ 115 ].…”
Section: Disorders Of Phosphate Homeostasismentioning
confidence: 99%
“…When given to hemodialysis patients, oral nicotinamide reduced hyperphosphatemia (128), although treatment was associated with significant gastrointestinal side effects that may limit its clinical usefulness. Phosphophloretin, a phosphorylated form of the plant chalcone phloretin, has been shown to be a competitive inhibitor of renal (100) and intestinal sodium-dependent phosphate transport in rabbits (98), rats (98), and humans (99) and to reduce serum phosphate levels in normal (98) and uremic rats (101). Finally, JTP-59557, a triazole derivative, is a noncompetitive inhibitor of phosphate transport across the rat small intestine in vivo, which is probably due to an action on NaPi-IIb (82).…”
Section: Intestinal Phosphate Transport In Crfmentioning
confidence: 99%